Neomycin sulfate 130, tilmicosin 320, enrofloxacin 238, VC 23, calcium pantothenate above 130, corn continued to weaken
Cephalosporins and penicillins
Ceftiofur sodium and ceftiofur hydrochloride are stable, ceftiofur sodium is about 2000, ceftiofur hydrochloride is 1200-1470, and cefquinoxime sulfate is 5840-6000. Entering late April, terminals gradually returned to normal, and the market has room for upside.
Amoxicillin continues to be strong, with a quotation of 260-270, and an increase of 2.1% in the first quarter of 2023. The share of foreign trade exports has increased. The overall production capacity is stretched in the short term, and manufacturers are willing to adjust prices.
Amoxicillin sodium, slightly up.
Potassium amoxicillin and clavulanate, the procurement demand is not strong, the price has room for negotiation, the market price is around 800, the main manufacturers: Inner Mongolia Federation, Weiqida, New Era.
Ampicillin, ampicillin sodium, the price is high, the supply of ampicillin is tight, the sodium salt is affected by it, and the market is unstable, ampicillin 288; ampicillin sodium 356-398.
Penicillin sodium (potassium), with lower cost performance and substitutability, the total market volume continued to shrink, and the market price of penicillin sodium was around 200; the price of penicillin potassium industrial salt was 140-148. The increase in the second quarter stopped, and the transaction volume recovered slowly.
Tetracyclines and Chloramphenicols
Doxycycline hydrochloride, the market is stalemate, the price is relatively stable in the low period, the market price is 378-390, and the price in the same period of 2022 is 425, a year-on-year decrease of 10.1%.
Oxytetracycline, oxytetracycline hydrochloride, stable, oxytetracycline, the market price is around 82; oxytetracycline hydrochloride, the market price is below 100, the price is relatively stable, the market price is relatively transparent, and there is room for bargaining for bulk products.
Chlortetracycline hydrochloride is running relatively strong, the market demand is picking up, and the market price is around 200. Common manufacturers: Pucheng Zhengda, Jinhe Biology, Fukang Pharmaceutical.
For Florfenicol, the price continues to be weak, the production capacity is almost saturated, the market demand is limited, and the competition is becoming increasingly fierce. Focus on the recent focus, the quotation range is 338-358, and the Asia-Pacific Yihe Data Analysis Center focuses on products.
Macrolides and other antibiotics
Tylosin tartrate rose steadily, the terminal demand was weak, the market prosperity index decreased, and the market transaction price range was 260-270.
The prices of tilmicosin and tilmicosin phosphate are stable, and the price of tilmicosin is 318-329; the price of tilmicosin phosphate is 288-305.
Tivalamectin tartrate continued to run at a low level, with a market price of 515-540, a drop of 8.7% in the first quarter; the price was 523 in the same period last year.
Erythromycin thiocyanate, quoted at 405-420, has an overall downward trend in the first quarter, with a range of 2.3%, an increase of 12.5% over the same period last year, and is currently at a high level. The value of this product was underestimated in the early stage, and the manufacturer will increase the price by more than 400 in 2022, which is highly accepted by the market. It is an important class of intermediates for the synthesis of macrolides such as erythromycin, roxithromycin, azithromycin, and clarithromycin.
Lincomycin hydrochloride is operating at a low level, and the price difference between manufacturers is increasing. The price range is 279-299. The price in the first quarter dropped by 5.26%, which is 8.5% lower than the same period last year. Manufacturers: Ningxia Taiyixin, Yichang East Sunshine, Shandong Qifa, Shandong Lukang, Livzon (Ningxia).
For colistin sulfate, the upstream ex-factory price has been adjusted, and the quotation in the terminal market has risen. The market quotation is 95-100.
The demand for tiamulin fumarate continues to decline, and it will take time to recover. The quotation is around 188, which will drop by 8.9% in the first quarter of 2023. It is currently at a historical low, and the highest price in 2018 is around 390. From 290 at the beginning of 2022, it has soared all the way to 190 now, a drop of 34.5%. How will the future trend pay attention to the Asia-Pacific Yihe Data Analysis Center.
Neomycin sulfate, down, 130-145, the price did not fluctuate greatly after the meeting in Qingdao, and the advantages of leading enterprises are still obvious. The annual average price in 2020 is 146, the annual highest price is 170, and the lowest value is 130; the annual average price in 2021 is 143; the annual average price in 2022 is 150.
Spectinomycin hydrochloride, sales slowed down slightly. The annual average price in 2020 is 570; the annual average price in 2021 is 562; the annual average price in 2022 is 543.
Gentamicin sulfate continues to be at a high level, with few inquiries recently, and the market quotation range is 1050-1525.
Streptomycin sulfate, stable operation, relatively stable competition pattern, quotation range 255-288.
Apramycin sulfate continues to rise, and the supply is sufficient. Asia-Pacific Ease and Data Center will pay attention to you. The current market price is 210-220.
Kanamycin monosulfate, slightly rising, the market price is 305; common brands: Shandong Qifa, Gutian Fuxing.
Sulfadiazine (sodium), slightly oscillating, the quotation is 190-210. According to statistics from the Asia-Pacific Yihe Data Analysis Center, the highest price will reach around 280 during 2019-2021, and the price will start to drop in 2022. In addition, some companies continue to expand their production and go public, their production capacity is saturated, and their profits are declining, gradually entering the stage of survival of the fittest.
Sulfamethazine (sodium), weak operation, transaction price 97-100.
Sulfamethoxazole (sodium) rose slightly, with a market price of 137.
Sulfamethoxine (sodium), stable, offer 265.
Sulfa-methoxine (sodium), the price has been lowered, the supply of goods is sufficient, and the transaction is frequent. As the vane of sulfa products, it always follows the general trend of the market. The market quotation is 251-280; the price in the same period in 2022 is 309; the annual price in 2020-2021 is above 300, and the Asia-Pacific Yihe Data Analysis Center expects to fluctuate in the short term.
Sodium sulfachlorpyrazine, with a steady decline, the market price is 282-300.
Sulfachlordazine sodium continues to be at a low level, and the market has not made any major moves recently. The market price is around 180, and manufacturers are less motivated to produce.
Sodium sulfaquinoxaline is weak, and the market price is around 300. In 2021, the highest record will reach 385, a drop of 24%.
Trimethoprim and lactate, as sulfonamide synergists, have not had a major breakthrough in market turnover, and the current prices are high, with the market quotation of trimethoprim lactate at 188 and the market quotation of trimethoprim at 235. Manufacturers of trimethoprim lactate: Shouguang Fukang, Chiping Yuanheng, Weifang Yikang, Shandong Fumeile, Shijiazhuang Liwei.
Enrofloxacin and enrofloxacin hydrochloride are making steady progress. Among quinolones, they are relatively easy to sell in volume. In recent years, restrictions on veterinary use of such raw materials have led to fluctuations in the total volume, and foreign trade exports are stable; Qingdao API After the meeting, it maintained a steady growth trend. The highest price of enrofloxacin 238 in 2021 reached 256; the annual average price in 2020 was 206; the market price of enrofloxacin hydrochloride was 230-239.
Ciprofloxacin lactate and ciprofloxacin hydrochloride were quoted at 228, slowly rising. At the beginning of February this year, the price dropped to around 200, and the price began to increase in early March.
Sarafloxacin hydrochloride, stable operation. Sarafloxacin hydrochloride is another new animal-specific drug after enrofloxacin. It was developed and marketed by Abbott of the United States. The antibacterial activity of this product is stronger than that of difloxacin, norfloxacin, ofloxacin, and butylamine. Kanamycin and tobramycin have the same antibacterial activity against anaerobic bacteria as ciprofloxacin.
Marbofloxacin, weak operation.
Diclazuril, down, quoted at 1430.
Albendazole, the market is stable, the supply is sufficient, and the quotation is 150-168. Albendazole market analysis: The price in 2020 is 240. The price in the same period in 2019 was 205, and the highest price in June rose to 276, a historical high. The supply of goods continued to be tight until July 2020, and the price began to fall, and fell to less than 200 in August; 2021 In the third and fourth quarters of the year, it hovered in the 155-170 range.
Fenbendazole is stable, with less supply, and the price is 285. In 2020, the price once rose to around 500.
Abamectin, weak operation, the market price 720-730.
Ivermectin, the market is at a low level, the terminal demand is reduced, and the market quotation range is 1000-1150. The annual average price in 2020 is 1280; the annual average price in 2021 is 1500; the downward mode will start in 2022.
Toquzhuli, the low level is stable, the quotation is 1100-1180, and the quotation in the same period last year was around 1500.
Levamisole hydrochloride, operating at a high level, is a variety with a relatively large market capacity among anti-parasitic products. Manufacturers are highly motivated to put it into production, and the market price is 422; the price in the same period in 2022 is 450, a decrease of 3.5%. Price 445 for the same period in 2021.
Metronidazole, stable, market price 85.
Praziquantel, High, 600-620.
For Dimenidazole, the supply of goods has increased, the market has returned to normal, and the price has gradually dropped. The market price is 127. In 2018, the price is around 80, and the price will increase steadily every year thereafter. In the first half of 2022, the price is stable, with an average transaction price of 118, and the price rebounded in the fourth quarter of the second half of the year, breaking through 160.
Antipyretic, analgesic, antiasthmatic, improve immunity
Flunixin Meglumine, Downlink, 620-660.
Analgin fluctuated slightly, and the quotation was around 90.
Acetaminophen, low, the market price is around 58.
Aminopyrine, stable, price 100.
Aspirin, market offer 28.
Taurine, the terminal consumption is stable for a long time, the price is more affected by accidental factors, and the market quotation is within 20.
Carbasalate calcium, the price is low, around 37, there are many manufacturers, the price war continues to seesaw, and it is currently in the stage of survival of the fittest.
Veterinary drug excipients and others
For acemequine, some manufacturers stopped reporting, and the later price adjustment is expected to rise.
Sodium salicylate, the price is stable, the market price is 25-30.
For sodium carbonate, the market price has gone down collectively, and the tonnage price is 3000-3260.
Sodium citrate is stable at a high level, and the tonnage price quoted by the factory is 16200-17300.
Sodium camphorsulfonate, low stable 69-82.
Chlorpheniramine is generally stable, and the market price is 190-210. According to the statistics of Asia-Pacific Yihe Data Analysis Center, the price is around 140-160 in 2018-2019. Chlorpheniramine is mainly imported, and the impact of the general environment has a restraining effect on the price.
Glucose, running smoothly, the tonnage transaction price is 4900-6200.
The price of Jiayi powder and starch has gone up.
Beta cyclodextrin, stable situation, market price 25-33.
Chinese veterinary medicine
Shuanghuanglian extract, slightly up, 80-102.
Astragalus polysaccharide, stable, 45-95.
Scutellaria baicalensis extract, the market is improving, 305-354.
Licorice Extract, 99-100.
Honeysuckle Extract, Stabilized, 200-230.
VC, sustained and stable, about 23 for feed grade, 45 for pharmaceutical grade.
VA, stable operation, the manufacturer’s low-price orders are tightened, 92 for mixing materials, and 110 for water-soluble.
VB1, transaction prices increased, foreign trade inquiries increased, nitric acid 122, hydrochloric acid 160.
VB2, the transaction price moves up, the market quotation is 80% 103, 98% 362.
VB6, the ex-factory price of the manufacturer is firm, and the quotation is above 120. According to the environmental assessment, in order to further improve the company’s production chain and provide market competitiveness, Shengda plans to invest 424 million yuan to implement an annual output of 1,500 tons of vitamin B6 in Zhejiang Tiantai Economic Development Zone.
For VB12, mainstream factories have raised prices, and the quotations are above 110.
VD3, the price is going up, you can pay attention to it in the later stage, 57 for mixing materials, 67 for water soluble.
VE, the price is stable, the demand is weak, the mixing material is 83, and the water-soluble is 88.
VK3, down in a narrow range, the market price is above 115.
Calcium pantothenate, the market fluctuates greatly, customers mainly buy and use immediately, and the quotation is above 130.
Niacinamide continues to rise, raw materials are in short supply, and the price is 40-50.
2% biotin, weak, profit compression, market price 41.
Folic acid, rising steadily, continues to be tense, and the quotation is around 220.
Corn prices continued to weaken on the 25th. The main production areas ushered in the warmer weather. Due to the rainy and snowy weather, the backlog of corn faced a significant increase. Feed companies were cautious in purchasing, and their willingness to replenish stocks was not good. The price continued to remain weak. From late April to late May, with the recovery of the farming market continuing to advance and superimposing grass-roots corn grain sources gradually bottoming out, grain traders are more reluctant to sell, and the bullish atmosphere for corn prices is gradually becoming stronger. It is predicted that the late April-May It is very likely that the spot price of corn will weaken first and then become strong, and the probability of the price stopping falling and rising around the middle of May will gradually increase.
On the 25th, the price of DDGS was strong. Recently, some domestic corn ethanol enterprises have shut down their devices for maintenance, and the supply of DDGS has decreased. Feed enterprises have maintained low raw material inventories in the early stage and mainly replenished their stocks with just-needed needs. The goods situation has gradually improved, and alcohol companies have strong sentiments to hold up prices. It is expected that DDGS will still have a strong trend in the short term.
CBOT soybean futures continued to fall as Brazil’s record-breaking soybean harvest caused concerns about weak demand for U.S. soybean exports. The price of premiums and discounts at Brazilian ports remained low, improving domestic supply while promoting a rapid drop in the cost of imported soybeans. The number of domestic soybeans cleared for customs increased, and the operating rate resumed after arriving at the oil plant. down. However, soybean meal rebounded slightly after oil mills and traders took the opportunity to raise prices due to the increased demand for feed farming companies to pick up goods before May 1st.
Cotton meal prices are relatively stable. Recently, the cost of imported soybeans has dropped and the operating rate of domestic oil plants has resumed. The tense spot situation of soybean meal has eased, and the overall price of soybean meal has weakened, which is negative for cotton meal. The operating rate is not high, and the supply of cotton meal is limited; and the price of cottonseed is firm, and the cost side plays a certain supporting role. The short-term adjustment of cotton meal tends to be weaker, but the range is limited.